Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 1;48(6):634-647.
doi: 10.1188/21.ONF.634-647.

Systematic Review of Cognitive Impairment in Colorectal Cancer Survivors Who Received Chemotherapy

Affiliations

Systematic Review of Cognitive Impairment in Colorectal Cancer Survivors Who Received Chemotherapy

Ya-Ning Chan et al. Oncol Nurs Forum. .

Abstract

Problem identification: Cognitive impairment is a common and troublesome side effect experienced by many cancer survivors. It can have a significant impact on survivors' ability to function and enjoy a high quality of life. However, most cognitive impairment research has focused on breast cancer survivors, despite the high rates of colorectal cancer and the toxicity of treatment agents in some colorectal cancer chemotherapeutic regimens, which have been linked to cognitive impairment. This review provides a novel synthesis of what is known about cognitive impairment in colorectal cancer survivors.

Literature search: CINAHL®, Cochrane Library, Embase®, PsycINFO®, and PubMed® were systematically searched by a health sciences librarian.

Data evaluation: Data were extracted across studies; findings about the prevalence, severity, and correlates of cognitive impairment were synthesized.

Synthesis: Across findings from 26 articles representing 24 independent studies, 13%-57% of participants had cognitive impairment. Potential demographic, physiologic, and psychological correlates of cognitive impairment were identified.

Implications for practice: Findings indicate a need to focus research and patient assessments on early identification of risk factors, assessing for existing cognitive deficits and testing interventions to decrease cognitive impairment in colorectal cancer survivors.

Keywords: chemotherapy; cognitive function; cognitive impairment; colorectal cancer.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
PRISMA Flow Diagram

Similar articles

Cited by

References

    1. Aaldriks AA, van der Geest LGM, Giltay EJ, le Cessie S, Portielje JEA, Tanis BC, … Maartense E (2013). Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. Journal of Geriatric Oncology, 4(3), 218–226. 10.1016/j.jgo.2013.04.001 - DOI - PubMed
    1. Alacacioglu A, Binicier O, Gungor O, Oztop I, Dirioz M, & Yilmaz U (2010). Quality of life, anxiety, and depression in Turkish colorectal cancer patients. Supportive Care in Cancer, 18(4), 417–421. 10.1007/s00520-009-0679-2 - DOI - PubMed
    1. Andreis F, Ferri M, Mazzocchi M, Meriggi F, Rizzi A, Rota L, … Zaniboni A (2013). Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study. Supportive Care in Cancer, 21(2), 583–590. 10.1007/s00520-012-1560-2 - DOI - PubMed
    1. Bender CM, Gentry AL, Brufsky AM, Casillo FE, Cohen SM, Dailey MM, … Sereika SM (2014). Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncology Nursing Forum, 41(3), 274–285. 10.1188/14.ONF.274-285 - DOI - PMC - PubMed
    1. Bray VJ, Dhillon HM, & Vardy JL (2018). Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship, 12(4), 537–559. 10.1007/s11764-018-0692-x - DOI - PubMed

Publication types